2019
DOI: 10.1002/ajmg.a.61414
|View full text |Cite
|
Sign up to set email alerts
|

Biallelic variants p.Arg1133Cys and p.Arg1379Cys in COL2A1: Further delineation of phenotypic spectrum of recessive Type 2 collagenopathies

Abstract: The phenotypic spectrum of Type 2 collagenopathies ranges from lethal achondrogenesis Type 2 to milder osteoarthritis with mild chondrodysplasia. All of them are monoallelic except for the two recent reports showing that biallelic variants in COL2A1 can cause spondyloepiphyseal dysplasia congenita in two children. Here we report two additional families with homozygous variants, c.4135C>T (p.Arg1379Cys) and c.3190C>T (p.Arg1133Cys) in COL2A1 resulting in two distinct skeletal dysplasia phenotypes of inter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 14 publications
3
6
0
Order By: Relevance
“…Patients with mutations in the C-terminal region present with milder phenotypes with some characteristic symptoms, probably because the variant has limited influence on the mature type II collagen [ 11 ]. Brachydactyly, especially of the middle and distal phalanges, seems to be the most common clinical feature of variants in the C‐terminal region [ 3 , 12 ], which was also observed in the present case. Further, variants in the C-terminal propeptide are also associated with platyspondylic skeletal dysplasia Torrance type(MIM#151210) and with Spondyloperipheral dysplasia (SPPD, MIM#271700) [ 13 ].…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…Patients with mutations in the C-terminal region present with milder phenotypes with some characteristic symptoms, probably because the variant has limited influence on the mature type II collagen [ 11 ]. Brachydactyly, especially of the middle and distal phalanges, seems to be the most common clinical feature of variants in the C‐terminal region [ 3 , 12 ], which was also observed in the present case. Further, variants in the C-terminal propeptide are also associated with platyspondylic skeletal dysplasia Torrance type(MIM#151210) and with Spondyloperipheral dysplasia (SPPD, MIM#271700) [ 13 ].…”
Section: Discussionsupporting
confidence: 80%
“…This was supported by Barat‐Houari et al [ 4 ], who described a more severe patient with SEDC with homozygosity. However, Girisha et al [ 3 ] then reported four patients with bi-allelic variants in COL2A1 which rarely caused SEDC. In type II collagenopathies dominantly inherited, more than 100 COL2A1 variants have been reported in patients diagnosed with SEDC, and most of the variants are located in the triple-helical domain (74% Gly replacements and 10% Arg-to-Cys substitutions) [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Rare variants were retrieved with minor allele frequency of < 1% in population databases [Exome Aggregation Consortium (ExAC) and gnomAD 54,55 ] and our in-house data. Variants were prioritized for the phenotypes 56 .…”
Section: Molecular Genetic Analysis Genomicmentioning
confidence: 99%
“…To date, no clear genotype–phenotype correlations have been obtained in type II collagenopathies, which is most likely associated with the existence of the inter- and intrafamilial variability of clinical manifestations, differences in the specificity of clinical manifestations in patients with the same pathogenic variants, age-related evolution of phenotypes, and evidence of marked genetic heterogeneity due to some cases with an autosomal recessive type of inheritance [ 13 , 15 , 23 , 24 , 25 , 26 ]. Nevertheless, conducting a clinical and genetic analysis of various nosological variants of the skeletal collagenopathies spectrum can improve our understanding of the pathogenetic mechanisms and more accurately predict their course at the early stages, improving an individual’s medical care and quality of life [ 27 ].…”
Section: Introductionmentioning
confidence: 99%